MAP2K7 and cancer: Examples include the compensatory activation of PI3K/Akt following mTOR inhibition driven by upstream receptor tyrosine kinase activation [1,2,3,4] and feedback activation of B- and C-RAF upon MEK inhibition, especially in the context of RAS-driven cancers [5,6].